# Frontier AI labs are moving into biotech to speed up drug R&D

> Original title: Why might the frontier labs be interested in biotech? https://x.com/i/article/2116091252068462592

- Source: X search: AI startup funding (we raised, seed, Series A)
- Published: 2026-10-30T09:18:08.000Z
- Bad Influence: https://badinfluence.news/items/eiju3wa0i5gd0938c527645ee
- Original: https://x.com/EganPeltan/status/2116097309276856552

## Summary

OpenAI acquired Orchestra, an operational platform for drug programs, and Anthropic released vignettes on Claude helping teams accelerate drug development along with its acquisition of Mithril Medicines. The author argues the labs' motivations are not primarily financial but aim to prove new human-AI collaboration methods for physical-world productivity. The post notes that drugs deliver lasting benefits, while drug development takes years, as with Eli Lilly's retatrutide, which entered Phase 1 in 2019.

## Post

Why might the frontier labs be interested in biotech? https://x.com/i/article/2116091252068462592